CLINICAL_TRIALS
ClinicalTrials.gov record update
High-Intensity Interval Training (HIT) for Breast Cancer Patients During Trastuzumab Use
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02454777
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:14.219976+00:00
- Published At
- 2021-04-05T00:00:00+00:00
- Record Updated At
- 2021-04-05
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Stage IA Breast Cancer", "Stage IB Breast Cancer", "Stage IIA Breast Cancer", "Stage IIB Breast Cancer", "Stage IIIA Breast Cancer", "Stage IIIB Breast Cancer", "Stage IIIC Breast Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-04-05"- protocolSection.identificationModule.nctId
"NCT02454777"- protocolSection.identificationModule.officialTitle
"High-Intensity Interval Training (HIT) for Breast Cancer Patients During Trastuzumab Use"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.